PL1928438T3 - Zastosowanie ibudilastu do leczenia uzależnień od środków odurzających - Google Patents
Zastosowanie ibudilastu do leczenia uzależnień od środków odurzającychInfo
- Publication number
- PL1928438T3 PL1928438T3 PL06815512T PL06815512T PL1928438T3 PL 1928438 T3 PL1928438 T3 PL 1928438T3 PL 06815512 T PL06815512 T PL 06815512T PL 06815512 T PL06815512 T PL 06815512T PL 1928438 T3 PL1928438 T3 PL 1928438T3
- Authority
- PL
- Poland
- Prior art keywords
- ibudilast
- treating drug
- drug addictions
- addictions
- treating
- Prior art date
Links
- ZJVFLBOZORBYFE-UHFFFAOYSA-N Ibudilast Chemical compound C1=CC=CC2=C(C(=O)C(C)C)C(C(C)C)=NN21 ZJVFLBOZORBYFE-UHFFFAOYSA-N 0.000 title 1
- 206010013663 drug dependence Diseases 0.000 title 1
- 229960002491 ibudilast Drugs 0.000 title 1
- 208000011117 substance-related disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72056805P | 2005-09-26 | 2005-09-26 | |
| US81003806P | 2006-05-31 | 2006-05-31 | |
| EP06815512A EP1928438B1 (en) | 2005-09-26 | 2006-09-26 | Use of ibudilast for treating drug addictions |
| PCT/US2006/037563 WO2007038551A2 (en) | 2005-09-26 | 2006-09-26 | Use of ibudilast for treating drug and behavioral addictions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1928438T3 true PL1928438T3 (pl) | 2013-08-30 |
Family
ID=37806904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06815512T PL1928438T3 (pl) | 2005-09-26 | 2006-09-26 | Zastosowanie ibudilastu do leczenia uzależnień od środków odurzających |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7915285B2 (pl) |
| EP (1) | EP1928438B1 (pl) |
| JP (1) | JP5411504B2 (pl) |
| AU (1) | AU2006294758A1 (pl) |
| BR (1) | BRPI0616344A2 (pl) |
| CA (1) | CA2623072A1 (pl) |
| DK (1) | DK1928438T3 (pl) |
| ES (1) | ES2412858T3 (pl) |
| PL (1) | PL1928438T3 (pl) |
| PT (1) | PT1928438E (pl) |
| RU (1) | RU2008116720A (pl) |
| WO (1) | WO2007038551A2 (pl) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110275664A1 (en) * | 2005-09-26 | 2011-11-10 | The Regents Of The University Of Colorado,A Body Corporate | Method for treating drug and behavioral addictions |
| EP1928438B1 (en) | 2005-09-26 | 2013-03-20 | Avigen, Inc. | Use of ibudilast for treating drug addictions |
| WO2007142923A1 (en) * | 2006-05-31 | 2007-12-13 | Avigen, Inc. | Mif inhibitors for treating neuropathic pain and associated syndromes |
| EP2026804A1 (en) * | 2006-05-31 | 2009-02-25 | Avigen, Inc. | Ibudilast for inhibiting macrophage migration inhibitory factor (mif) activity |
| WO2008045641A2 (en) * | 2006-10-10 | 2008-04-17 | The University Of Chicago | Composition s comprising a benzodiazepine, an alcohol aversive agent and an abuse aversive agent |
| CA2669463A1 (en) * | 2006-11-09 | 2008-05-15 | Avigen, Inc. | Method for treating delirium |
| MX2009006672A (es) * | 2006-12-19 | 2009-10-26 | Univ Virginia | Efectos combinados de topiramato y ondansetron sobre el consumo de alcohol. |
| PL2131841T3 (pl) * | 2007-01-30 | 2013-03-29 | Avigen Inc | Sposoby leczenia bólu ostrego |
| WO2008095086A2 (en) * | 2007-01-31 | 2008-08-07 | University Of Virginia Patent Foundation | Topiramate plus naltrexone for the treatment of addictive disorders |
| US8637528B2 (en) | 2007-03-27 | 2014-01-28 | Omeros Corporation | Use of PDE7 inhibitors for the treatment of movement disorders |
| US20080287402A1 (en) * | 2007-05-03 | 2008-11-20 | Johnson Kirk W | Use of a glial attenuator to prevent amplified pain responses caused by glial priming |
| US20090028816A1 (en) * | 2007-07-27 | 2009-01-29 | Lance Sultzbaugh | Treatment of depression, psychosis, and anxiety |
| JP2010537990A (ja) * | 2007-08-27 | 2010-12-09 | ユニバーシティ オブ バージニア パテント ファウンデーション | アルコール中毒および薬物嗜癖の処置のための医薬の組み合わせ |
| KR20100127799A (ko) | 2008-02-28 | 2010-12-06 | 유니버시티 오브 버지니아 페이턴트 파운데이션 | 세로토닌 운반체 유전자 및 알콜중독의 치료 |
| WO2010065930A1 (en) * | 2008-12-04 | 2010-06-10 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating or preventing narcotic withdrawal symptoms |
| CA2785056A1 (en) * | 2009-12-22 | 2011-07-21 | Pondera Biotechnologies, LLC | Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications |
| US20110218215A1 (en) * | 2010-03-04 | 2011-09-08 | Holly Benjamin D | Compositions and Methods for Treating Social Anxiety |
| PL2801625T3 (pl) | 2010-07-02 | 2018-06-29 | University Of Virginia Patent Foundation | Molekularne, genetyczne podejście do leczenia i diagnozy uzależnienia od alkoholu i leków |
| US9220715B2 (en) | 2010-11-08 | 2015-12-29 | Omeros Corporation | Treatment of addiction and impulse-control disorders using PDE7 inhibitors |
| AU2013201989B2 (en) * | 2010-11-08 | 2016-01-07 | Omeros Corporation | Treatment of addiction and impulse-control disorders using PDE7 inhibitors |
| KR102385359B1 (ko) * | 2010-11-08 | 2022-04-11 | 오메로스 코포레이션 | Pde7 억제제를 사용한 중독 및 충동-조절 장애의 치료 |
| JP2014525927A (ja) * | 2011-08-18 | 2014-10-02 | シャイアー アーゲー | 治療法に使用される５−ｈｔ４受容体アゴニスト及びｐｄｅ４阻害剤の組合せ |
| EP2751137A4 (en) | 2011-09-09 | 2015-06-03 | Univ Virginia Patent Found | MOLECULAR GENETIC APPROACH FOR THE TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG INDEPENDENCE |
| US9610285B2 (en) | 2011-11-16 | 2017-04-04 | University Of Florida Research Foundation, Incorporated | Compositions for controlling food intake and uses therefor |
| RU2665134C2 (ru) * | 2012-05-07 | 2018-08-28 | Омерос Корпорейшн | Лечение зависимости и расстройств побуждений с применением ингибиторов фдэ7 |
| AU2013266793B2 (en) * | 2012-05-07 | 2016-08-04 | Omeros Corporation | Treatment of addiction and impulse-control disorders using PDE7 inhibitors |
| WO2015023871A1 (en) * | 2013-08-15 | 2015-02-19 | Medicinova, Inc. | Treatment of alcoholism using ibudilast |
| US9192570B2 (en) | 2013-12-20 | 2015-11-24 | AntiOP, Inc. | Intranasal naloxone compositions and methods of making and using same |
| US10188645B2 (en) * | 2015-08-26 | 2019-01-29 | Ian Cain Smith | Methods and compositions for ameliorating symptoms of termination of opioid pain therapy |
| US20190151294A1 (en) * | 2016-05-10 | 2019-05-23 | Medicinova, Inc. | Treatment of alcoholism and depression and/or dysphoric mood using ibudilast |
| US20190201494A1 (en) * | 2016-09-13 | 2019-07-04 | Stc Unm | Compositions and methods for treating nicotine withdrawal |
| WO2019055942A1 (en) * | 2017-09-18 | 2019-03-21 | SEN-JAM Pharmaceutical LLC | METHODS AND COMPOSITIONS FOR INHIBITING OPIOID TOLERANCE |
| CA3222744A1 (en) * | 2021-06-09 | 2022-12-15 | Proniras Corporation | Methods of treating or preventing conditions associated with opiate withdrawal or opiate relapse |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
| US12303604B1 (en) | 2024-10-16 | 2025-05-20 | Currax Pharmaceuticals Llc | Pharmaceutical formulations comprising naltrexone and/or bupropion |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5496836A (en) * | 1994-05-05 | 1996-03-05 | Mount Sinai School Of Medicine Of The City University Of New York | Use of famotidine and related compounds in the treatment of movement disorders |
| JP3601898B2 (ja) * | 1996-02-14 | 2004-12-15 | 俊隆 鍋島 | 薬物依存形成抑制剤 |
| WO1999063929A2 (en) | 1998-06-08 | 1999-12-16 | Advanced Medicine, Inc. | Multibinding inhibitors of microsomal triglyceride transferase protein |
| US6057368A (en) * | 1998-08-05 | 2000-05-02 | Brookhaven Science Associates Llc | Treatment of addiction and addiction-related behavior |
| FR2797402B1 (fr) | 1999-07-15 | 2004-03-12 | Biomerieux Stelhys | Utilisation d'un polypeptide pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune |
| US6953774B2 (en) * | 2000-08-11 | 2005-10-11 | Applied Research Systems Ars Holding N.V. | Methods of inducing ovulation |
| UY27304A1 (es) | 2001-05-24 | 2002-12-31 | Avanir Pharmaceuticals | Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación |
| EP2319838A1 (en) | 2002-06-07 | 2011-05-11 | Cortical Pty Ltd | Therapeutic Molecules and Methods-1 |
| WO2003104178A1 (en) | 2002-06-07 | 2003-12-18 | Cortical Pty Ltd | Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif) |
| EP1570847B1 (en) * | 2002-12-03 | 2012-04-25 | Kyorin Pharmaceutical Co., Ltd. | Phosphodiesterase 10a inhibitors for use in the treatment of parkinson's disease, huntington's disease and schizophrenia |
| AU2003299750A1 (en) | 2002-12-20 | 2004-07-22 | Irm Llc | Differential tumor cytotoxocity compounds and compositions |
| US7261882B2 (en) | 2003-06-23 | 2007-08-28 | Reagents Of The University Of Colorado | Methods for treating neuropathic pain by administering IL-10 polypeptides |
| WO2005058304A1 (en) | 2003-12-17 | 2005-06-30 | Cortical Pty Ltd | Implantable device containing inhibitor of macrophage migration inhibitory factor |
| GB0423405D0 (en) | 2004-10-21 | 2004-11-24 | Novartis Ag | Organic compounds |
| WO2006063048A2 (en) | 2004-12-06 | 2006-06-15 | Avigen, Inc. | Ibudilast for treating neuropathic pain and associated syndromes |
| GB0507695D0 (en) | 2005-04-15 | 2005-05-25 | Novartis Ag | Organic compounds |
| EP1928438B1 (en) | 2005-09-26 | 2013-03-20 | Avigen, Inc. | Use of ibudilast for treating drug addictions |
| WO2007047978A2 (en) * | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| EP2026804A1 (en) | 2006-05-31 | 2009-02-25 | Avigen, Inc. | Ibudilast for inhibiting macrophage migration inhibitory factor (mif) activity |
| CA2669463A1 (en) | 2006-11-09 | 2008-05-15 | Avigen, Inc. | Method for treating delirium |
| PL2131841T3 (pl) | 2007-01-30 | 2013-03-29 | Avigen Inc | Sposoby leczenia bólu ostrego |
-
2006
- 2006-09-26 EP EP06815512A patent/EP1928438B1/en active Active
- 2006-09-26 WO PCT/US2006/037563 patent/WO2007038551A2/en not_active Ceased
- 2006-09-26 US US11/527,757 patent/US7915285B2/en active Active
- 2006-09-26 DK DK06815512.6T patent/DK1928438T3/da active
- 2006-09-26 ES ES06815512T patent/ES2412858T3/es active Active
- 2006-09-26 AU AU2006294758A patent/AU2006294758A1/en not_active Abandoned
- 2006-09-26 PT PT68155126T patent/PT1928438E/pt unknown
- 2006-09-26 JP JP2008532501A patent/JP5411504B2/ja active Active
- 2006-09-26 BR BRPI0616344-0A patent/BRPI0616344A2/pt not_active Application Discontinuation
- 2006-09-26 RU RU2008116720/14A patent/RU2008116720A/ru not_active Application Discontinuation
- 2006-09-26 PL PL06815512T patent/PL1928438T3/pl unknown
- 2006-09-26 CA CA002623072A patent/CA2623072A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT1928438E (pt) | 2013-04-03 |
| EP1928438B1 (en) | 2013-03-20 |
| WO2007038551A3 (en) | 2007-06-28 |
| DK1928438T3 (da) | 2013-04-22 |
| WO2007038551A2 (en) | 2007-04-05 |
| US7915285B2 (en) | 2011-03-29 |
| BRPI0616344A2 (pt) | 2011-06-14 |
| AU2006294758A1 (en) | 2007-04-05 |
| RU2008116720A (ru) | 2009-11-10 |
| EP1928438A2 (en) | 2008-06-11 |
| CA2623072A1 (en) | 2007-04-05 |
| HK1120737A1 (en) | 2009-04-09 |
| US20070072899A1 (en) | 2007-03-29 |
| ES2412858T3 (es) | 2013-07-12 |
| JP5411504B2 (ja) | 2014-02-12 |
| JP2009509975A (ja) | 2009-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0602178D0 (en) | Therapeutic treatment | |
| IL198663A0 (en) | Tissue treatment methods | |
| IL192299A0 (en) | Use of nitrooxyderivative of drug for the treatment of muscular dystrophies | |
| PL2034920T3 (pl) | Urządzenie do laserowych zabiegów dermatologicznych | |
| GB0606604D0 (en) | Treatment apparatus | |
| EP2078536A4 (en) | MEDICAL DEVICE | |
| BRPI0914294A2 (pt) | aparelho de tratamento de cápsulas | |
| IL193747A0 (en) | New therapeutic combinations for the treatment of depression | |
| NO2016023I1 (no) | Glycerol fenylbutyrat | |
| SI2205245T1 (sl) | Terapevtska uporaba diaminofenotiazinov | |
| ITRE20060026A1 (it) | Apparecchio per trattamenti medicinali | |
| ITRE20060127A1 (it) | Apparecchio per trattamenti medicali | |
| AP2008004593A0 (en) | Antivral drugs for treatment of arenavirus infection | |
| HRP20181877T1 (hr) | Postupci za liječenje lijekovima koji uklanjaju amonijak | |
| IL187715A0 (en) | Use of phenylsemicarbazones for seed treatment | |
| GB0715790D0 (en) | Drug combination for the treatment of sialorrhoea | |
| GB2452204B (en) | Head worn medical treatment apparatus | |
| GB0608655D0 (en) | Therapeutic Treatment | |
| IL192933A0 (en) | Benzoisoindole derivatives for the treatment of pain | |
| EP1842498A4 (en) | TREATMENT DEVICE FOR AN ENDOSCOPE | |
| GB0610909D0 (en) | Therapeutic treatment | |
| ZA200904478B (en) | Novel therapeutic use for treating leukaemia | |
| SI1928438T1 (sl) | Uporaba ibudilasta za zdravljenje zasvojenosti z drogami | |
| ZA200800393B (en) | Use of phenylsemicarbazones for seed treatment | |
| GB0625112D0 (en) | Apparatus for skin treatment |